Infliximab and Upadacitinib Demonstrate Superior Early Onset of Efficacy in Biologic-Naïve Ulcerative Colitis with Severe Endoscopic Disease Citation: Wong ECL, Jairath V, Dulai PS, et al. Am J Gastroenterol. 2026 Feb 2. Epub ahead of print. PMID: 41626838.
The YODA Project